HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways.

Abstract
BACKGROUND AND PURPOSE Angiotensin-(1-7) [Ang-(1-7)] has anti-inflammatory effects in models of cardiovascular disease and arthritis, but its effects in asthma are unknown. We investigated whether Ang-(1-7) has anti-inflammatory actions in a murine model of asthma. EXPERIMENTAL APPROACH The effects of Ang-(1-7) alone or in combination with the MAS1 receptor antagonist, A779, were evaluated over a 4 day period in an ovalbumin-challenged mouse model of allergic asthma. On day 5, bronchoalveolar lavage was performed, and lungs were sectioned and assessed histologically for quantification of goblet cells, perivascular and peribronchial inflammation and fibrosis. Biochemical analysis of the pro-inflammatory ERK1/2 and IκB-α was assessed. In addition, the effect of Ang-(1-7) on proliferation of human peripheral blood mononuclear cells (HPBMC) was investigated. KEY RESULTS Ang-(1-7) attenuated ovalbumin-induced increases in total cell counts, eosinophils, lymphocytes and neutrophils. Ang-(1-7) also decreased the ovalbumin-induced perivascular and peribronchial inflammation, fibrosis and goblet cell hyper/metaplasia. Additionally, Ang-(1-7) reduced the ovalbumin-induced increase in the phosphorylation of ERK1/2 and IκB-α. These effects of Ang-(1-7) were reversed by the MAS1 receptor antagonist A779. Furthermore, Ang-(1-7) inhibited phytohaemagglutinin (PHA)-induced HPBMC proliferation. CONCLUSION AND IMPLICATIONS Ang-(1-7), via its MAS1 receptor, acts as an anti-inflammatory pathway in allergic asthma, implying that activation of the MAS1 receptor may represent a novel approach to asthma therapy.
AuthorsAhmed Z El-Hashim, Waleed M Renno, Raj Raghupathy, Heba T Abduo, Saghir Akhtar, Ibrahim F Benter
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 166 Issue 6 Pg. 1964-76 (Jul 2012) ISSN: 1476-5381 [Electronic] England
PMID22339213 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.
Chemical References
  • 7-Ala-angiotensin (1-7)
  • Allergens
  • MAS1 protein, human
  • Mas1 protein, mouse
  • NF-kappa B
  • Peptide Fragments
  • Phytohemagglutinins
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Receptors, G-Protein-Coupled
  • Angiotensin II
  • Ovalbumin
  • Angiotensin I
  • angiotensin I (1-7)
Topics
  • Allergens (administration & dosage)
  • Angiotensin I (pharmacology)
  • Angiotensin II (analogs & derivatives, pharmacology)
  • Animals
  • Asthma (immunology, pathology)
  • Bronchoalveolar Lavage Fluid (cytology)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Humans
  • Leukocytes, Mononuclear (drug effects, immunology)
  • MAP Kinase Signaling System (drug effects)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (immunology)
  • Ovalbumin (administration & dosage)
  • Peptide Fragments (pharmacology)
  • Phytohemagglutinins (pharmacology)
  • Pneumonia (immunology, pathology)
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins (immunology)
  • Receptors, G-Protein-Coupled (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: